Czech Republic - Lipid Modifying Medicine Use
Since 2014, Czech Republic Lipid Modifying Medicine Use jumped by 4.5% year on year. With 140.2 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, the country was number 8 comparing other countries in Lipid Modifying Medicine Use. Czech Republic is overtaken by Australia, which was number 7 with 141.2 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Netherlands with 137.3 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Denmark topped the ranking with 159.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, a growth of 3.5% compared to 2018. United Kingdom, Norway and Belgium respectively ranked number 2, 3 and 4 in this ranking. Lithuania recorded the best 5 years average growth at +18.8% per year, while Slovakia recorded the worst performance at -8.7% per year.
Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
---|---|
2019 | 140.20 |
2018 | 135.30 |
2017 | 130.40 |
2016 | 125.10 |
2015 | 117.70 |
How does Czech Republic rank in Lipid Modifying Medicine Use?
# | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Denmark
|
160 | 2019 | +3.5 % | +3.8 % | View data | |
2 |
#2
United Kingdom
|
153 | 2019 | +1.7 % | +2.3 % | View data | |
7 |
#7
Australia
|
141 | 2019 | +1.7 % | +1.4 % | View data | |
8 |
#8
Czech Republic
|
140 | 2019 | +3.6 % | +4.5 % | View data | |
9 |
#9
Netherlands
|
137 | 2019 | +2.3 % | +3.3 % | View data |